Palantir's Perfection Premium: Blowout Fundamentals Meet a C-Suite Cashing Out

Palantir's Q2 revenue jumped 93% to $1.94B, but insider selling and a 133x FCF valuation raise concerns. Growth and risk coexist.

There is a peculiar tension at the heart of Palantir's current market narrative. On one side sits an operating performance that has silenced years of skepticism — revenue growth that most software companies can only dream of, margins that defy the industry's growth-at-all-costs orthodoxy, and a balance sheet with zero debt. On the other side sits a valuation that leaves no room for error, a growing chorus of insider selling, and a stock that has already sprinted nearly 50 percent higher in a single month.

Both realities are true simultaneously. That is what makes this story so compelling — and so fraught.

The Numbers That Changed the Debate

The second-quarter results were, by any measure, exceptional. Revenue hit $1.94 billion, a 93 percent jump year over year, with GAAP margins of 55 percent. The US commercial business expanded 149 percent, net revenue retention reached 157 percent, and remaining performance obligations climbed 103 percent to $4.9 billion. CEO Alex Karp called the quarter "otherworldly" and went further, predicting the current growth pace is sustainable for another 18 months.

That is not merely executive bravado. The company raised its full-year guidance to $8.15–$8.158 billion, an 82 percent increase over the prior year. The growth is also broadening: government revenue stood at roughly $3.2 billion against about $2.9 billion from commercial clients, a gap that is closing visibly. Palantir is no longer just a defense contractor with a side business — it is becoming a genuinely diversified software enterprise.

The expansion into operational software is arguably the most significant strategic shift. Material planning, digital twins, supply chain orchestration — Palantir is moving from an analytical tool into the operational backbone of industrial companies. That explains why growth is so broadly distributed across manufacturing, energy, healthcare, and financial services, rather than dependent on any single anchor customer.

The Pentagon Engine Keeps Humming

The defense side of the business continues to deliver concrete milestones. The Maven Smart System, already designated a "Program of Record" in the regular defense budget since March, is now translating into hard figures: the Pentagon's fiscal 2027 budget proposal allocates $2.30 billion over five years for Maven and the related Joint Fires Network. William Blair reaffirmed its "Outperform" rating on August 26, arguing Maven could exceed $1 billion in annual recurring revenue.

There is also fresh contract activity. Together with Raytheon, Palantir secured a framework agreement worth roughly $876 million for the Army's Distributed Common Ground System. And the company pushed back against reports of a lost $875 million contract with France's DGSI intelligence agency, pointing to a contract extension signed in late 2025.

On the product front, Palantir introduced "AIP Evolve" in late August, a beta feature designed to coordinate fleets of AI agents that autonomously optimize systems. The company also expanded its Foundry offering with role-based compute profiles — a technical but meaningful detail for large enterprise customers concerned about access control.

The Insider Exodus

Here is where the story gets uncomfortable. CEO Alexander Karp sold nearly 492,000 shares on August 20 for approximately $86.06 million, tied to tax withholding on vesting RSUs under a Rule 10b5-1 plan. Director Alexander D. Moore and Chief Accounting Officer Jeffrey Buckley also sold packages in August.

Technically, these are automated, plan-based transactions for tax purposes — the standard mechanism by which executives pay taxes on vested equity. That mechanical explanation matters. But the sheer clustering of sales into a period when the stock had already run hard is hard to ignore.

Seeking Alpha's Juxtaposed Ideas downgraded Palantir from "Buy" to "Hold" on August 18, citing the stretched valuation after the post-earnings rally and the persistent insider selling. That call is now more than four weeks old, but it underscores that valuation concerns were on the table long before they became consensus.

The Valuation Conundrum

At $186.29 in US trading, Palantir has been valued at 133 times free cash flow and 72.7 times revenue. These are not multiples that growth rates alone can justify — they represent a bet on years of flawless execution.

The analyst community reflects this split. Thirty-two firms cover the stock, with price targets ranging from $80 to $255 and an average of $191.68. UBS sees $220, Piper Sandler $230 — both anchored in accelerating commercialization beyond the traditional government business. The bears, meanwhile, point to the same numbers and see a market that has gotten ahead of itself.

The stock's technical position adds another layer. With a relative strength index around 66–69, the shares are overbought in the short term. The 52-week high of €179.98 sits roughly 11–12 percent above current levels — a sign that the market is catching its breath after the recent surge.

Political Hedging and a Wider Lens

One detail worth noting: reports indicate Palantir is shifting its political contributions toward Democrats ahead of the midterms, including larger campaign donations. That reads as hedging against regulatory risk should the House majority change hands. A company actively managing political risk in this way is also signaling that it does not take smooth sailing in government business for granted.

The Bottom Line

The fundamental story at Palantir remains intact: accelerating growth, expanding margins, deepening government relationships, and a product portfolio that is becoming more operationally embedded with each quarter. A debt-free balance sheet with triple-digit commercial growth and retention above 150 percent is rare operational substance.

But the valuation leaves virtually no margin for disappointment. The combination of strong operational news and heavy insider selling suggests a meaningful portion of the good news is already priced in. At €158.50–€160.88, with a 48–51 percent gain over the past month, this is a stock that has moved far, fast.

Those who believe Karp's 18-month growth forecast will read the current consolidation as a pause before the next leg up. Those who distrust the extreme valuation will find confirmation in every pullback. After this quarter, both camps have legitimate arguments — an unusual position for a stock that generates so many headlines.